51st week of 2016 patent applcation highlights part 22 |
Patent application number | Title | Published |
20160368919 | NOVEL PYRIDINE PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS | 2016-12-22 |
20160368920 | Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer | 2016-12-22 |
20160368921 | SUBSTITUTED POLYCYCLIC CARBAMOLYPYRIDONE DERIVATIVE | 2016-12-22 |
20160368922 | 2-OXO-1,3,8-TRIAZASPIRO[4.5]DECAN-3-YL] CARBOXYLIC ACID DERIVATIVES | 2016-12-22 |
20160368923 | PYRIMIDINONES AS FACTOR XIA INHIBITORS | 2016-12-22 |
20160368924 | PURINONE COMPOUNDS AS KINASE INHIBITORS | 2016-12-22 |
20160368925 | SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | 2016-12-22 |
20160368926 | SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | 2016-12-22 |
20160368927 | SYNTHESIS OF MAHANINE AND RELATED COMPOUNDS | 2016-12-22 |
20160368928 | MELAMPOMAGNOLIDE B DERIVATIVES | 2016-12-22 |
20160368929 | MELAMPOMAGNOLIDE B DERIVATIVES | 2016-12-22 |
20160368930 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2016-12-22 |
20160368931 | PHARMACEUTICALLY ACTIVE DIMERS LINKED THROUGH PHENOLIC HYDROXYL GROUPS | 2016-12-22 |
20160368932 | BUPRENORPHINE DIMER AND ITS USE IN TREATMENT OF GASTROINTESTINAL DISORDERS | 2016-12-22 |
20160368933 | FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3 | 2016-12-22 |
20160368934 | HYDRIDOSILAPYRROLES, HYDRIDOSILAAZAPYRROLES, THIASILACYCLOPENTANES, METHOD FOR PREPARATION THEREOF, AND REACTION PRODUCTS THEREFROM | 2016-12-22 |
20160368935 | AZOLE SILANE COMPOUND, SURFACE TREATMENT SOLUTION, SURFACE TREATMENT METHOD, AND USE THEREOF | 2016-12-22 |
20160368936 | PROCESS FOR PREPARING DIALKYLPHOSPHINATE AND A PRODUCT THEREOF | 2016-12-22 |
20160368937 | PHOSPHONIUM COMPOUND, PREPARATION METHOD THEREOF, EPOXY RESIN COMPOSITION INCLUDING THE SAME, AND SEMICONDUCTOR DEVICE PREPARED BY USING THE SAME | 2016-12-22 |
20160368938 | CO-CRYSTALS, SALTS AND SOLID FORMS OF TENOFOVIR ALAFENAMIDE | 2016-12-22 |
20160368939 | ORGANOMETALLIC 2-CYANO-2-AMINOBENZOATE-PROPYL DERIVATES AND THEIR USE AS ANTHELMINTICS | 2016-12-22 |
20160368940 | Dithiolene Metal Complex Colorless IR Absorbers | 2016-12-22 |
20160368941 | NOVEL METHODS OF ISOMERIZING CARBOHYDRATES | 2016-12-22 |
20160368942 | ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS | 2016-12-22 |
20160368943 | SUBSTITUTED PURINE COMPOUNDS | 2016-12-22 |
20160368944 | LINKED PURINE PTERIN HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS | 2016-12-22 |
20160368945 | CHIRAL SPECIFIC BORON-CONTAINING COMPOUNDS AND THEIR USE IN TREATING CANCER OR AMYLOIDOSIS | 2016-12-22 |
20160368946 | TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS | 2016-12-22 |
20160368947 | NMDA Receptor Modulators and Uses Thereof | 2016-12-22 |
20160368948 | IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF | 2016-12-22 |
20160368949 | INFLUENZA VIRUS RECOMBINANT PROTEINS | 2016-12-22 |
20160368950 | Immunogenic Compositions and Methods | 2016-12-22 |
20160368951 | ANTIGEN CHIMERA, ANTIGEN COMPOSITION, VACCINE, METHOD OF PREPARING THE SAME AND CASSETTE THEREOF | 2016-12-22 |
20160368952 | Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus | 2016-12-22 |
20160368953 | BACTERIOCIN WITH NOVEL ACTIVITY | 2016-12-22 |
20160368954 | METHODS FOR TREATING DISORDERS THAT INVOLVE IMMUNOGLOBULIN A | 2016-12-22 |
20160368955 | COMPOUND, USE, ANTI-TUMOR PHARMACEUTICAL COMPOSITION,GENE CONSTRCT FOR POLYPEPTIDE EXPRESSION, PROCESS FOR THE PRODUCTION, PROCESS FOR THE EVALUATION OF TUMOR CELLS, METHOD OF SENSITIZATION OF TUMOR CELLS TO CHEMOTHERAPEUTIC | 2016-12-22 |
20160368956 | METHOD OF PREVENTIVELY TREATING A SUBJECT AT THE RISK OF DEVELOPING INFECTIONS OF A RESPIRATORY VIRUS | 2016-12-22 |
20160368957 | IL-17 Binding Compounds and Medical Uses Thereof | 2016-12-22 |
20160368958 | HJURP PEPTIDES AND VACCINES INCLUDING THE SAME | 2016-12-22 |
20160368959 | SURFACE-BINDING PEPTIDE | 2016-12-22 |
20160368960 | GLUCAGON AND GLP-1 CO-AGONIST COMPOUNDS | 2016-12-22 |
20160368961 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | 2016-12-22 |
20160368962 | Melanocortin Receptor Ligands | 2016-12-22 |
20160368963 | TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF | 2016-12-22 |
20160368964 | TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF | 2016-12-22 |
20160368965 | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers | 2016-12-22 |
20160368966 | NOVEL a4B7 PEPTIDE DIMER ANTAGONISTS | 2016-12-22 |
20160368967 | METHODS AND COMPOSITIONS FOR THE INHIBITION OF TRPV4 | 2016-12-22 |
20160368968 | METHOD FOR OBTAINING THIN FIBRIL COLLAGEN BY CONTACTING NATIVE COLLAGEN WITH AN ANTIBODY | 2016-12-22 |
20160368969 | NOVEL POLYVALENT IMMUNOTHERAPEUTICS OF HIGH SPECIFICITY BASED ON MODIFIED ANTIBODIES AND A LYOPHILIZED INJECTABLE FORMULATION HIGHLY SAFE AND EFFECTIVE | 2016-12-22 |
20160368970 | PROCESS | 2016-12-22 |
20160368971 | IGA MULTI-SPECIFIC BINDING MOLECULES | 2016-12-22 |
20160368972 | Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein | 2016-12-22 |
20160368973 | ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF | 2016-12-22 |
20160368974 | IMMUNOGLOBULIN-LIKE MOLECULES DIRECTED AGAINST FIBRONECTIN-EDA | 2016-12-22 |
20160368975 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA | 2016-12-22 |
20160368976 | ANTIBODIES TO KALLIDIN AND DES-ARG9-KALLIDIN | 2016-12-22 |
20160368977 | HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE | 2016-12-22 |
20160368978 | AMINO ACID SEQUENCES DIRECTED AGAINST THE ANGIOPOIETIN/TIE SYSTEM AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF DISEASES AND DISORDERS RELATED TO ANGIOGENESIS | 2016-12-22 |
20160368979 | ANTI EOTAXIN-2 ANTIBODIES THAT RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINES | 2016-12-22 |
20160368980 | INHIBITION OF GRANULOCYTE COLONY STIMULATING FACTOR IN THE TREATMENT OF CANCER | 2016-12-22 |
20160368981 | HUMAN ANTI-IL-32 ANTIBODIES | 2016-12-22 |
20160368982 | Treatment of Dermatological Pathologies | 2016-12-22 |
20160368983 | COMPOSITIONS AND METHODS FOR TREATING OBESITY | 2016-12-22 |
20160368984 | Compositions Comprising Antibodies to Lingo or Fragments Thereof | 2016-12-22 |
20160368985 | HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE | 2016-12-22 |
20160368986 | Therapeutic Use of Anti-CD22 Antibodies for Inducing Trogocytosis | 2016-12-22 |
20160368987 | BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DISEASES | 2016-12-22 |
20160368988 | HUMAN CD3 BINDING ANTIBODY | 2016-12-22 |
20160368989 | ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF | 2016-12-22 |
20160368990 | ANTI B7-H3 ANTIBODY | 2016-12-22 |
20160368991 | SOLUBLE MIC NEUTRALIZING MONOCLONAL ANTIBODY FOR TREATING CANCER | 2016-12-22 |
20160368992 | A METHOD OF INCREASING GIPCR SIGNALIZATION IN THE CELLS OF A SCOLIOTIC SUBJECT | 2016-12-22 |
20160368993 | ALPHA-V BETA-6 INTEGRIN-BINDING ANTIBODY FRAGMENTS | 2016-12-22 |
20160368994 | ANTI-CLL-1 ANTIBODIES AND METHODS OF USE | 2016-12-22 |
20160368995 | IDENTIFICATION OF CXCR8, A NOVEL CHEMOKINE RECEPTOR | 2016-12-22 |
20160368996 | METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND ENHANCING TUMOR VACCINES | 2016-12-22 |
20160368997 | Antibodies, Uses & Methods | 2016-12-22 |
20160368998 | FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB | 2016-12-22 |
20160368999 | ANTIBODY FORMULATION | 2016-12-22 |
20160369000 | 4-1BB BINDING MOLECULES | 2016-12-22 |
20160369001 | NOVEL ANTI-TRANSFERRIN RECEPTOR ANTIBODY THAT PASSES THROUGH BLOOD-BRAIN BARRIER | 2016-12-22 |
20160369002 | MULTISPECIFIC NK ENGAGER PROTEINS | 2016-12-22 |
20160369003 | ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS | 2016-12-22 |
20160369004 | ANTI-MET IN COMBINATION WITH ANTI-VEGFR2 ANTIBODIES THERAPY FOR CANCER | 2016-12-22 |
20160369005 | ANTI-C10ORF54 ANTIBODIES AND USES THEREOF | 2016-12-22 |
20160369006 | Fc-ENHANCED ANTI-WT1/HLA ANTIBODY | 2016-12-22 |
20160369007 | IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A | 2016-12-22 |
20160369008 | NOVEL ANTI-HUMAN PAI-1 ANTIBODY | 2016-12-22 |
20160369009 | HUMANISED ANTI KALLIKREIN-2 ANTIBODY | 2016-12-22 |
20160369010 | ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE | 2016-12-22 |
20160369011 | CYS80 Conjugated Immunoglobulins | 2016-12-22 |
20160369012 | HYBRID CONSTANT REGIONS | 2016-12-22 |
20160369013 | Dissolution of Oxidized Cellulose and Particle Preparation by Solvent and Non-Solvent Precipitation | 2016-12-22 |
20160369014 | PROCESS FOR THE PRODUCTION OF WATER AND SOLVENT-FREE NITRILE RUBBERS | 2016-12-22 |
20160369015 | Silane Modified Elastomeric Polymers | 2016-12-22 |
20160369016 | Process Using Substituted Metallocene Catalysts and Products Therefrom | 2016-12-22 |
20160369017 | CURABLE COMPOSITION, POLYMER FUNCTIONAL CURED PRODUCT, WATER-SOLUBLE ACRYLAMIDE COMPOUND, AND METHOD FOR MANUFACTURING SAME | 2016-12-22 |
20160369018 | PREPARATION METHOD OF VINYL CHLORIDE POLYMER AND VINYL CHLORIDE POLYMER PREPARED THEREBY | 2016-12-22 |